CRBP vs KEYS · $102.3M cap vs P/E 57, rev $5.16B
Corbus Pharmaceuticals Holding (CRBP) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported CRBP revenue for 2022-12-31 was $0. Net income was -$42.3M. CRBP currently screens at market cap $102.3M.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
CRBP currently screens at market cap $102.3M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the CRBP and KEYS stock pages for the full models.
Not investment advice.